Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 30, 2023

Management of acute metabolic crisis in TANGO2 deficiency: a case report

  • Emel Yılmaz-Gümüş ORCID logo EMAIL logo , Nursel H. Elcioglu , Emine Genç , Şule Arıcı , Gülten Öztürk , Özge Yapıcı , Figen Akalın and Burcu Öztürk-Hişmi ORCID logo

Abstract

Objectives

TANGO2 deficiency is a rare inborn error of metabolism, with distinct clinical features. The clinical presentations of TANGO2 deficiency are developmental delay, speech difficulties, intellectual disability, non-life-threatening paroxysmal neurologic episodes (TANGO2 spells), acute metabolic crises, cardiac crises, seizures and hypothyroidism. Patients may die in acute metabolic crises. Here we report our experience in the management of an acute metabolic crisis in TANGO2 deficiency.

Case presentation

A 9-year-old patient diagnosed with TANGO2 deficiency was admitted with fever, fatigue, unable to walk. In follow up, encephalopathy, rhabdomyolysis and arrhythmia were detected. Vitamin B-complex was started. Our patient’s mental status and rhabdomyolysis improved dramatically, and cardiac crises ended without Torsades de pointes, ventricular tachycardia and/or fibrillation or myocardial dysfunction.

Conclusions

With this report, we aimed to show the effectiveness of vitamin B-complex in the management of acute metabolic crises.


Corresponding author: Emel Yılmaz-Gümüş, Department of Pediatrics, Division of Pediatric Metabolic Diseases, Marmara University School of Medicine, Fevzi Çakmak Mah. Muhsin Yazıcıoğlu Cad. No. 10 Pendik 34899, İstanbul, Türkiye, Phone: +905553178960, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Lalani, SR, Liu, P, Rosenfeld, JA, Watkin, LB, Chiang, T, Leduc, MS, et al.. Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to Bi-allelic TANGO2 mutations. Am J Hum Genet 2016;98:347–57. https://doi.org/10.1016/j.ajhg.2015.12.008.Search in Google Scholar PubMed PubMed Central

2. Kremer, LS, Distelmaier, F, Alhaddad, B, Hempel, M, Iuso, A, Küpper, C, et al.. Bi-Allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardiomyopathy. Am J Hum Genet 2016;98:358–62. https://doi.org/10.1016/j.ajhg.2015.12.009.Search in Google Scholar PubMed PubMed Central

3. Milev, MP, Saint-Dic, D, Zardoui, K, Klopstock, T, Law, C, Distelmaier, F, et al.. The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria. J Inherit Metab Dis 2021;44:426–37. https://doi.org/10.1002/jimd.12312.Search in Google Scholar PubMed

4. Bérat, CM, Montealegre, S, Wiedemann, A, Nuzum, MLC, Blondel, A, Debruge, H, et al.. Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect. J Inherit Metab Dis 2021;44:415–25. https://doi.org/10.1002/jimd.12314.Search in Google Scholar PubMed

5. Miyake, CY, Burrage, L, Glinton, K, Houck, K, Hoyos-Martinez, A, Graham, B, et al.. TANGO2 deficiency. In: Adam, MP, Mirzaa, GM, Pagon, RA, Wallace, SE, Bean, LJH, Gripp, KW, et al.. editors GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle; 2018.1993–2023.Search in Google Scholar

6. Mingirulli, N, Pyle, A, Hathazi, D, Alston, CL, Kohlschmidt, N, O’Grady, G, et al.. Clinical presentation and proteomic signature of patients with TANGO2 mutations. J Inherit Metab Dis 2020;43:297–308. https://doi.org/10.1002/jimd.12156.Search in Google Scholar PubMed PubMed Central

7. Miyake, CY, Lay, EJ, Soler-Alfonso, C, Glinton, KE, Houck, KM, Tosur, M, et al.. Natural history of TANGO2 deficiency disorder: baseline assessment of 73 patients. Genet Med 2023;25:100352. https://doi.org/10.1016/j.gim.2022.11.020.Search in Google Scholar PubMed PubMed Central

8. Zutt, R, van der Kooi, AJ, Linthorst, GE, Wanders, RJ, de Visser, M. Rhabdomyolysis: review of the literature. Neuromuscul Disord 2014;24:651–9. https://doi.org/10.1016/j.nmd.2014.05.005.Search in Google Scholar PubMed

9. Dines, JN, Golden-Grant, K, LaCroix, A, Muir, AM, Cintrón, DL, McWalter, K, et al.. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants. Genet Med 2019;21:601–7. https://doi.org/10.1038/s41436-018-0137-y.Search in Google Scholar PubMed PubMed Central

10. Miyake, CY, Lay, EJ, Beach, CM, Ceresnak, SR, Delauz, CM, Howard, TS, et al.. Cardiac crises: cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. Heart Rhythm 2022;19:1673–81. https://doi.org/10.1016/j.hrthm.2022.05.009.Search in Google Scholar PubMed

11. Vincent, GM. Long QT syndrome. Cardiol Clin 2000;18:309–25. https://doi.org/10.1016/s0733-8651(05)70143-0.Search in Google Scholar PubMed

12. Asadi, P, Milev, MP, Saint-Dic, D, Gamberi, C, Sacher, M. Vitamin B5, a coenzyme A precursor, rescues TANGO2 deficiency disease-associated defects in Drosophila and human cells. J Inherit Metab Dis 2023;46:358–68. https://doi.org/10.1002/jimd.12579.Search in Google Scholar PubMed PubMed Central

Received: 2023-04-19
Accepted: 2023-06-20
Published Online: 2023-06-30
Published in Print: 2023-10-26

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 12.6.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2023-0172/html
Scroll to top button